Dr. John E. Fitzgerald, MD

Dr. Fitzgerald practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Fitzgerald's NPI, 1245334580, was assigned on September 8, 2006. Dr. Fitzgerald graduated from WashU Medicine in 1989. Dr. Fitzgerald holds Texas license H8040.

Dr. Fitzgerald's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Fitzgerald's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Fitzgerald is also affiliated with Parkland Memorial Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Fitzgerald to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fitzgerald practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Fitzgerald's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Fitzgerald is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Fitzgerald is licensed in Texas.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), pneumonia and pulmonary fibrosis among the conditions Dr. Fitzgerald treats.

CMS data shows 798 Medicare services from Dr. Fitzgerald across 10 procedure codes in 2024, for 432 Medicare patients. Medicare paid $32,197 for them.

CMS counts 432 Medicare patients who saw Dr. Fitzgerald in 2024. The largest group is 65 to 74, with 186 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fitzgerald's median patient age at 65, with 58% women.

In 2024, Dr. Fitzgerald wrote 647 Medicare Part D claims for 143 patients. 57% of them were for generic drugs. CMS names the drug for 541 of them, across 16 drugs with 11 or more claims each, at $1,349,329 in total drug cost. In 2023, CMS named 675 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Fitzgerald for performance year 2024, reported as part of a group. Dr. Fitzgerald accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Fitzgerald, published from 2013 to 2021. Dr. Fitzgerald's most frequent co-authors are Traci N. Adams, MD, Kiran Batra, MD and John A. Belperio, MD.

Dmand AI links Dr. Fitzgerald to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis and Idiopathic Interstitial Pneumonias. Duke University sponsors the most, 2.

CMS Open Payments shows 63 general payments to Dr. Fitzgerald from 2 drug and device companies from 2017 to 2023. Speaker and faculty fees make up the largest share, 71% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $29,724.

Dmand AI lists 7 awards for Dr. Fitzgerald, most recently Best Doctors in Dallas in 2021.

Dr. Fitzgerald graduated from WashU Medicine in 1989. Dr. Fitzgerald is a member of ACCP, ATS and TMA.

Dr. Fitzgerald is in network with 24 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.